Cargando…

Finding a New Prognostic Biomarker for Metastatic Colorectal Cancer

Detalles Bibliográficos
Autor principal:	Kim, Hungdai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Coloproctology 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548141/ https://www.ncbi.nlm.nih.gov/pubmed/23346505 http://dx.doi.org/10.3393/jksc.2012.28.6.284

Ejemplares similares

Does Diabetes Really Impact on Postoperative Survival in Patients with Colorectal Cancer?
por: Kim, Hungdai
Publicado: (2010)

Clinical Implication of Colorectal Cancer Stem Cells: Still Has a Long Way to Go
por: Kim, Hungdai
Publicado: (2015)

Will the Stroma-derived Factor-1α (CXCL12)/CXCR4 Pathway Become a Major Concern for Advanced Colorectal Cancer?
por: Kim, Hungdai
Publicado: (2012)

The role of biomarker in later-line treatment for metastatic colorectal cancer
por: Kawakami, Takeshi, et al.
Publicado: (2023)

New prognostic models in metastatic renal cancer
por: Lim, Louise, et al.
Publicado: (2012)

Mechanical Bowel Preparation, Do It or Not: When Crossing a River, What Do People Do?
por: Kim, Hungdai
Publicado: (2017)

Metastatic Colorectal Cancer
por: Passardi, Alessandro, et al.
Publicado: (2021)

Hand-Assisted Laparoscopic Right Colectomy: Is It Useful?
por: Kim, Hungdai
Publicado: (2014)

Should Hand-Assisted Laparoscopic Surgery Be Placed in the Realm of Minimally Invasive Surgery?
por: Kim, Hungdai
Publicado: (2013)

Mechanical Bowel Preparation: Keep It or Abandon It?
por: Kim, Hungdai
Publicado: (2013)

Sham Feeding? Same Feeding?
por: Kim, Hungdai
Publicado: (2013)

The Wind of Change: Uncomplicated Diverticulitis
por: Kim, Hungdai
Publicado: (2015)

Anti-tumor Necrosis Factor Therapy for Crohn Disease: Friend or Foe to the Surgeon?
por: Kim, Hungdai
Publicado: (2015)

Prognostic markers for colorectal cancer
por: Tyrrell, Helen E.J., et al.
Publicado: (2018)

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
por: Thomsen, Maria, et al.
Publicado: (2016)

Biomarkers in colorectal cancer screening
por: Schab, Katarzyna, et al.
Publicado: (2017)

New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Serum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer
por: Lee, Sookyung, et al.
Publicado: (2016)

Epidemiology, Risk Factors, and Prevention of Colorectal Cancer-An English Version
por: Jung, Kyung Uk, et al.
Publicado: (2022)

Prognostic Role of MMPs in Colorectal Cancer
por: Baek, Moo-Jun
Publicado: (2011)

Syndecan-2 Methylation as a New Biomarker for Early Detection of Colorectal Neoplasm
por: Kim, Ji Hyun, et al.
Publicado: (2018)

Towards the era of precision medicine in metastatic colorectal cancer
por: Napolitano, Stefania, et al.
Publicado: (2020)

Microbiota: An Emerging Biomarker in Colorectal Cancer
por: Tsiaoussis, John, et al.
Publicado: (2021)

Factors Affecting the Outcome of a Pulmonary Resection for Metastatic Colorectal Cancer: Efficacy and Pitfalls
por: Kim, Ik Yong
Publicado: (2010)

Non-invasive actionable biomarkers for metastatic prostate cancer
por: Luo, Jun
Publicado: (2016)

Mitochondrial UQCRB as a new molecular prognostic biomarker of human colorectal cancer
por: Kim, Hyun-Chul, et al.
Publicado: (2017)

New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression
por: Ziranu, Pina, et al.
Publicado: (2023)

Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting
por: Riedl, Jakob Michael, et al.
Publicado: (2017)

Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer
por: Hamaguchi, Tetsuya, et al.
Publicado: (2019)

Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker?
por: Konukiewitz, Björn, et al.
Publicado: (2021)

Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers
por: Criscitiello, Carmen, et al.
Publicado: (2018)

Diagnostic, Prognostic, and Predictive Biomarkers in Breast Cancer
por: Li, Chia-Jung, et al.
Publicado: (2020)

CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
por: Yang, Mengyuan, et al.
Publicado: (2023)

Prognostic Value of Colorectal Cancer Biomarkers
por: Bianchi, Paolo, et al.
Publicado: (2011)

Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
por: Woo, Ji Won, et al.
Publicado: (2019)

New Biomarkers in Cancers
por: Novak, Daniel, et al.
Publicado: (2021)

Prognostic prediction of colorectal cancer using the C-reactive protein to albumin ratio: the importance of inflammatory biomarkers and their association with long-term outcomes
por: Lee, Chul Seung
Publicado: (2023)

Finding good biomarkers for sarcopenia
por: Scharf, Gesine, et al.
Publicado: (2012)

Ribonucleotide Reductase Subunit M2 Can Be New Molecular Target and Prognostic Biomarker of Hepatocellular Carcinoma
por: Kim, Hee Yeon, et al.
Publicado: (2014)

Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
por: Nissen, Neel I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_14r957uk5m6vf23glb6ngidg3v